Partnership combines AbTherx's proprietary Atlas™ Long CDR3 Technology with GPCR Therapeutics' deep expertise in GPCR biology to discover and develop antibodies for novel targets MOUNTAIN VIEW, CA / ...

It’s been a dark decade since he descended down that escalator. But there are signs of resistance and clear opportunities for ...